Wikidata

(Q63397645)

English

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)- Measure Up 1

clinical trial

In more languages

Statements

short name
Measure Up 1 (English)
0 references
title
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
AbbVie
0 references
country
Argentina
0 references
Australia
0 references
Bosnia and Herzegovina
0 references
Bulgaria
0 references
Canada
0 references
Colombia
0 references
Croatia
0 references
Denmark
0 references
Estonia
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Japan
0 references
Malaysia
0 references
New Zealand
0 references
Romania
0 references
Switzerland
0 references
Turkey
0 references
Ukraine
0 references
United Kingdom
0 references
start time
13 August 2018
0 references
end time
20 December 2019
0 references
number of participants
810
0 references
minimum age
12 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63397645&oldid=1857202870"